Tender For supply of medicine - brinzolamide 1 percent with brimonidine 0 point 2 percent with carbomer 970p and mannitol bak not more than 0 point 003 percent usfda approved with drop tainer , e d bimatoprost 0 point 03 percent bott of 3 ml , d brimonidine 2 mg ml bott of 5 ml , e d brimonidine tartarate plus timolol 0 point 5 percent , e d brinozolamide 1 percent , carboxy methyl cellulose 1 percent gel , e d chloramphenicol 0 point 5 percent plus dexamethasone sodium 0 point 1 percent bott of 5 ml , e d ciprofloxacin plus dexamethasone , e d cyclopentolate hcl 1 percent bott of 5ml , dorzolamide 2 plus plus timolol 0 point 5 percent bott of 5 ml , e d flurbiprofen sodium 0 point 3 percent bott of 5 ml , e d flurometholone 1mg ml bott of 5 ml , e d gatifloxacin 0 point 3 percent bott of 5 ml , gentamicin sulphate 0 point 3 percent w v gentamicin base with hydrocortisone acetate ip 1 percent w v eye ear drops bott of 5 ml , gatifloxacin 0 point 3 percent plus dexamathasone 0 point 5 percent eye drop 5 ml , e d hyaluronate sodium 0 point 1 percent w v 5ml , hydroxypropyl methyl cellulose eye drop 10 ml preservative free , hydroxypropyl methyl cellulose ophthalmic gel preservative free , e d hydroxypropyl methyl cellulose 0 point 3 w v eye drop 10 ml , e d ketorolac , e d ketotifen 0 point 005 percent , e d lotepredenol etabonate 0 point 5 percent bott of 5 ml , eye drop moxifloxacin hydrochloride and dexamethasone phsphate opthalmic solution with droptainer sysytem with 1 point 0 ml equivalent to moxifloxacin 5mg and dexamethasone 1mg in 1 ml , e d moxifloxacin hcl 0 point 3 percent , e d timolol maleate 0 point 5 percent bott 5 ml , e d moxifloxacin 0 ponit 5 percent preservative free eye drops , e d ofloxacin plus dexamethasone , ofloxacin 0 point 3 percent bott of 5 ml , e d olopatadine 0 point 2 percent with drop tainer system , e d olopatadine 1 percent plus ketorolac 0 point 4 percent , gatifloxacin hcl 0 point 3 percent plus prednisolone 1 percent w v eye drop 10 ml , e d nepafenac 0 point 1 percent , e d atropine , e d sodium hyaluronate 0 point 2 percent , e d sodium hyaluronate 1 percent 10mg ml , e d sulphacetamide 20 percent bott of 10ml , tobramycin 0 point 3 percent bott of 5 ml , nepafenac 0 point 1 precent w v with carbomer 970 p eye drop with drop tainer system usfda approved eye drop 5 ml , tropicamide eye solution 1 percent bott of 5 ml , brimonidine tartrate 0 point 2 percent eye drops 5 ml , povidone iodine germicidal gargle 2 precent w v , chloramphenicol 5 percent w v clotrimazole 1 percent w v betamethasone 0 point 25 erecent w v lignocaine hcl 2 percent w v in bott of 5 ml , nasal spray xylometazolin 0 point 14 mg 0 point 14 ml preservative free , clotrimazole 1 percent plus lignocaine 2 precent bott of 10 ml ear drop , resp soln levoslabutamol sulphate resp of 2 point 5ml , salbutamol 100mcg pack of 200 metered dose mdi , rotacap foracort 400mg , rotacap tiotropium bromide 18 mcg , rotacap budesonide 200 mcg , rotacap tiotropium bromide 18 mcg plus formetrol 12mcg
Tender For bid to ras bid to ras bid to ras supply of inj insulin analogue long acting basal plus long acting glp 1 analogue in pfs or pfp , diethyl ether solvent bott of 500 ml , 2 propanol and 1 propanol macetronium ethyl sulphate 0 point 2 percent 45 or 35 gm 100gm 500ml sterilium , inj morphine tubonic amp 15 mg per ml inj , inj pethedine 50 mg 1 ml inj , inj fosphenytoin 75 mg per ml 2ml ampoule , dulaglutide 0 point 75 mg solution for inj in perfilled pen , goserelin 3 point 6 mg prefilled syringe inj , ethamsylate 250 mg per 2 ml inj , inj digoxin 0 point 5 mg 2 ml , teething gel consisting of choline salicylate 9 percent w by v cetrimide ip 0 point 1 percent w by v bottle of 10 ml , 60 percent v by v ethyl alcohol with benzalkonium chloride glycerine dimethicone cyclopentasiloxane alkyl lactate propylene glycol methylparaben phenoxyethanol stearyl , chloroxylenol solution potassium hydroxide 13 point 6g chloroxylenol solution 50 point 5g oleic acid 7 point 5ml castor oil 63 point 0 g terpineal 100ml ethanol 96 percent 200ml dettol , tab torsemide 100 mg , l ornithine laspartate powder 5gm , terlipressin 1 mg plus 10 ml diluent or 0 point 10mg per ml 10 ml vial or amp , syrup metoclopramide 5mg per 5ml bott of 30ml , tab ethinyl estradiol 0 point 035mg cyproterone acetate 2mg pack of 21tab , betaxolol eye drops 0 point 2 percent 0 point 5 percent 5 ml , gentamicin sulphate 0 point 3 percent w by v gentamicin base with hydrocortisone acetate ip1 percent w by v eye and ear drops bott of 5 ml , ketotifen fumarate 0 point 005 percent eye drops bottle of 5 ml , povidone 5 percent eye drop bott of 5 ml , sodium chloride 6 percent w by w ointment tube of 3 gm , sodium chloride eye drops 5 percent 5 ml bott , antimicrobial hand gel containing ethyl alcohol 60 percent plus cyclomethicone c12 to 15 alkyl lactate plus cetyl lactate plus phenoxyethanol plus stearyl alcohol with moisturizer , haemostatic sponge gelatin 80 mm long 50mm broad 10 mm thick , cilostazole tab 100 mg , betahistine dihydrochloride 8mg tab , sodium cromoglycate nasal spray 2 percent w by v bottle of 20 ml , viscoat 0 point 75 ml opthalmic viscoelastic solution pfs , tab exemestane 25mg bid details/ 2 / 29
Tender For corrigendum : supply of polymyxin b 300 units antibiotic disc , minocycline 30mcg antibiotic disc , azithromycin 15 mcg antibiotic disc , levofloxacin 5 mcg antibiotic disc , cefixime 5 mcg antibiotic disc , ceftolozane tazobactum 75 10 mcg , ceftazidime avibactum 30 20 mcg , ceftaroline 30 mcg antibiotic disc , high level gentamicin 120 mcg , cefiderocol 30 ug disc